在社区药房实施过敏性鼻炎临床管理途径 (AR-CMaP) 的影响
Rachel House1,2, Vicky Kritikos1, Biljana Cvetkovski1,2
1Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Glebe, NSW, Australia.
Exploratory research in clinical and social pharmacy
|October 23, 2023
概括
过敏性鼻炎临床管理途径 (AR-CMaP) 提高了药剂师的认识,但并没有显著增加适当的药物购买量. 患者继续自我管理过敏性鼻炎,突出了根深蒂固的习惯.
科学领域:
- 药房实践 在药房实践.
- 临床管理 临床管理
- 过敏性疾病 过敏性疾病
背景情况:
- 过敏性鼻炎临床管理途径 (AR-CMaP) 是为了应对在澳大利亚社区药房设置中实施当前过敏性鼻炎 (AR) 准则的挑战而开发的.
- 该途径旨在支持药剂师为经历AR的患者提供最佳管理.
研究的目的:
- 评估AR-CMaP对患者行为和药剂师对社区药房AR管理的需求的影响.
- 评估药物适用性和药剂师参与后实施后的变化.
主要方法:
- 采用了横截面的前后研究设计.
- 在AR-CMaP实施之前和之后收集了患者购买药物的数据.
- 药剂师的需求和看法在培训前和之后被记录下来.
主要成果:
- 在适当的AR药物购买中观察到非统计学上显著的增加 (22.4%的AR-CMaP前与29.0%的AR-CMaP后).
- 患者与药剂师的咨询在实施后减少了 (52%前比37%后).
- 药剂师报告说,他们对障碍的认识增加,并更愿意与医疗保健提供者 (HCP) 合作.
结论:
- 尽管AR-CMaP没有显著增加最佳药物选择,但它使患者能够在没有不良影响的情况下自我治疗.
- 药剂师在AR管理中表现出更强的角色意识,以及更愿意与其他医疗人员合作.
- 未来的研究应该集中在帮助药剂师决策的工具上,并解决AR管理中的患者自我选择习惯.
相关概念视频
01:20Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
458
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
01:16Drugs Used in Upper Respiratory Disorders: Overview
265
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
265